Atrial fibrillation after cardiac surgery/cardiopulmonary bypass is associated with monocyte activation

Anesthesia and Analgesia

Volumn 101, Issue 1, 2005, Pages 17-23

  Fontes, Manuel L ^a   Mathew, Joseph P ^a   Rinder, Henry M ^a   Zelterman, Daniel ^a   Smith, Brian R ^a   Rinder, Christine S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD11B ANTIGEN; MYELOPEROXIDASE; TROPONIN I;

ADULT; AGED; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART MUSCLE; HEART RHYTHM; HEART SURGERY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORBIDITY; MORTALITY; NEUTROPHIL; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SINUS RHYTHM; UPREGULATION;

AGED; ANTIGENS, CD11B; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; CONSTRICTION; FEMALE; FLOW CYTOMETRY; HUMANS; INTRAOPERATIVE PERIOD; MACROPHAGE ACTIVATION; MALE; MONITORING, INTRAOPERATIVE; MONOCYTES; NEUTROPHILS; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; ROC CURVE;

EID: 20744442717     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000155260.93406.29     Document Type: Article

References (31)

1. Mathew J, Parks R, Savino J, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. JAMA 1996;276:300-6.
2. Maisel W, Rawn J, Stevenson W. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001;135:1061-73.
3. Hogue C, Hyder M. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Ann Thorac Surg 2000;69:300-6.
4. Almassi G, Schowalter T, Nicolosi A, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997;226:501-13.
5. Andrews T, Reimold S, Berlin J, Antman E. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized control trials. Circulation 1991;84:III236-44.
6. Stanley T, Mackensen G, Grocott H, et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94:290-5.
7. Hravnak M, Hoffman L, Saul M, et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Am J Crit Care 2002;11:228-38.
8. Siebert J, Anisimowicz L, Lango R, et al. Atrial fibrillation after coronary artery bypass grafting: does the type of procedure influence the early postoperative incidence? Eur J Cardiothorac Surg 2001;19:455-9.
9. Gaudino M, Andreotti F, Zamparelli R, et al. The -17G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation: is atrial fibrillation an inflammatory complication? Circulation 2001;108:II195-9.
10. Falk R. Etiology and complications of atrial fibrillation: insights from pathology studies. Am J Cardiol 1998;82:10N-7.
11. Frustaci A, Chimente C, Fulvio B, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997;96:1180-4.
12. A2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Ann Thorac Surg 2001;71:663-6.
13. Rinder C, Mathew J, Rinder H, et al. The platelet PlA2 polymorphism and platelet activation are associated with increased troponin I release after cardiopulmonary bypass. Anesthesiology. In press.
14. Rinder C, Bonan J, Rinder H, et al. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992;79:1201-5.
15. Xu X, Hakansson L. Degranulation of primary and secondary granules in adherent neutrophils. Scand J Immunol 2002;55:178-88.
16. Borregaard N, Cowland J. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997;89:3503-21.
17. Rinder C, Rinder H, Smith B, et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest 1995;96:1564-72.
18. Hamada Y, Kohtani T, Nakata T, et al. Blood transfusion under cardiopulmonary bypass is a possible inducer for inflammation. Kyobu Geka 2001;54:835-8.
19. Sakai TL, Whitten CW, O'Flaherty DN, et al. Changes in plasma atrial natriuretic peptide concentration during heart transplantation. J Cardiothorac Vasc Anesth 1992;6:686-91.
20. Smith C, Marlin S, Rothlein R, et al. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 1989;83:2008-17.
21. Rinder CS, Rinder HM, Tracey JB, et al. Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med 1997;129:592-602.
22. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-91.
23. Whitten CW, Hill GE, Ivy R, et al. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery?. Anesth Analg 1998;86:28-33.
24. Ascione R, Caputo M, Calori G, et al. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation 2000;102:1530-5.
25. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-25.
26. Yared JP, Starr NJ, Torres FK, et al. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg 2000;69:1420-4.
27. Edmunds LJ. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1998;66:S12-6.
28. Kappelmayer J, Bernabei A, Gikakis N, et al. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation. J Lab Clin Med 1993;121:118-26.
29. Amar D. Postoperative atrial fibrillation. Heart Disease 2002;4:117-23.
30. Aldea G, Soltow L, Chandler W, et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 2002;123:742-55.
31. Sundaram S, Gikakis N, Hack C, et al. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil, and contact activation in simulated extracorporeal circulation. Thromb Haemost 1996;75:76-82.